Antonios Markogiannakis

1.2k total citations
20 papers, 737 citations indexed

About

Antonios Markogiannakis is a scholar working on Molecular Medicine, Pharmacology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Antonios Markogiannakis has authored 20 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Medicine, 8 papers in Pharmacology and 5 papers in Applied Microbiology and Biotechnology. Recurrent topics in Antonios Markogiannakis's work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Antibiotic Use and Resistance (5 papers). Antonios Markogiannakis is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Antibiotic Use and Resistance (5 papers). Antonios Markogiannakis collaborates with scholars based in Greece. Antonios Markogiannakis's co-authors include George L. Daikos, L. S. Tzouvelekis, Maria Souli, Evangelia‐Theophano Piperaki, Athanasios Tsakris, Spyros Pournaras, N.J. Legakis, A. Ikonomidis, Antonios N. Maniatis and Maria Gazouli and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, The Annals of Thoracic Surgery and Clinical Microbiology and Infection.

In The Last Decade

Antonios Markogiannakis

19 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonios Markogiannakis Greece 11 565 215 210 176 165 20 737
Jesabel I. Rivera United States 9 721 1.3× 300 1.4× 197 0.9× 222 1.3× 170 1.0× 10 842
Theodoros Karampatakis Greece 13 498 0.9× 154 0.7× 146 0.7× 165 0.9× 176 1.1× 35 705
María Isabel Morosini Spain 18 480 0.8× 134 0.6× 158 0.8× 201 1.1× 105 0.6× 42 723
Laura J. Rojas United States 16 746 1.3× 213 1.0× 301 1.4× 189 1.1× 186 1.1× 48 893
Agila Kumari Pragasam India 19 611 1.1× 284 1.3× 189 0.9× 143 0.8× 158 1.0× 52 886
Doroti de Oliveira Garcia Brazil 16 656 1.2× 293 1.4× 169 0.8× 228 1.3× 87 0.5× 37 917
Gianluigi Lombardi Italy 13 531 0.9× 228 1.1× 142 0.7× 272 1.5× 123 0.7× 24 773
Maud Nilsson Sweden 16 650 1.2× 281 1.3× 166 0.8× 154 0.9× 133 0.8× 27 846
Fatima M’Zali France 17 792 1.4× 354 1.6× 118 0.6× 186 1.1× 139 0.8× 38 998
M. Carmen Conejo Spain 18 696 1.2× 222 1.0× 334 1.6× 247 1.4× 110 0.7× 39 920

Countries citing papers authored by Antonios Markogiannakis

Since Specialization
Citations

This map shows the geographic impact of Antonios Markogiannakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonios Markogiannakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonios Markogiannakis more than expected).

Fields of papers citing papers by Antonios Markogiannakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonios Markogiannakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonios Markogiannakis. The network helps show where Antonios Markogiannakis may publish in the future.

Co-authorship network of co-authors of Antonios Markogiannakis

This figure shows the co-authorship network connecting the top 25 collaborators of Antonios Markogiannakis. A scholar is included among the top collaborators of Antonios Markogiannakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonios Markogiannakis. Antonios Markogiannakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Samarkos, Michael, et al.. (2021). Restricted antimicrobial prescribing in an area of highly prevalent antimicrobial resistance. Infectious Diseases Now. 51(6). 526–531. 3 indexed citations
3.
Markogiannakis, Antonios, Maria N. Gamaletsou, Michael Samarkos, et al.. (2020). Impact of a non-compulsory antifungal stewardship program on overuse and misuse of antifungal agents in a tertiary care hospital. International Journal of Antimicrobial Agents. 57(1). 106255–106255. 17 indexed citations
4.
Tansarli, Giannoula S., Joseph Papaparaskevas, Michael Samarkos, et al.. (2018). Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis. International Journal of Antimicrobial Agents. 52(3). 397–403. 23 indexed citations
5.
Kambouris, Manousos E., Antonios Markogiannakis, Michael Arabatzis, et al.. (2017). Wireless Electrostimulation: A New Approach in Combating Infection?. Future Microbiology. 12(3). 255–265. 7 indexed citations
6.
Psichοgiou, Mina, Garyphalia Poulakou, Dimitrios Basoulis, et al.. (2017). Recent Advances in Antiretroviral Agents: Potent Integrase Inhibitors. Current Pharmaceutical Design. 23(18). 2552–2567. 14 indexed citations
7.
Tzouvelekis, L. S., Antonios Markogiannakis, Evangelia‐Theophano Piperaki, Maria Souli, & George L. Daikos. (2014). Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clinical Microbiology and Infection. 20(9). 862–872. 268 indexed citations
8.
Kosmidis, Chris, Garyphalia Poulakou, Antonios Markogiannakis, & George L. Daikos. (2012). Treatment options for infections caused by carbapenem-resistant gram-negative bacteria. Research Explorer (The University of Manchester). 6(1). 28–34. 6 indexed citations
9.
Markogiannakis, Antonios, A. Ikonomidis, Spyros Pournaras, et al.. (2008). Cross-Transmission of Multidrug-ResistantAcinetobacter baumanniiClonal Strains Causing Episodes of Sepsis in a Trauma Intensive Care Unit. Infection Control and Hospital Epidemiology. 29(5). 410–417. 63 indexed citations
10.
Kapetanakis, Emmanouil Ι., et al.. (2007). Bronchial Stump Buttressing With an Intercostal Muscle Flap in Diabetic Patients. The Annals of Thoracic Surgery. 84(3). 967–971. 41 indexed citations
11.
12.
Baltayiannis, Nikolaos, et al.. (2006). The Influence of Local Instillation of Fusidic Acid on the Development of Microbial Complications After Lung Resection. Journal of Chemotherapy. 18(3). 285–292. 3 indexed citations
13.
Ikonomidis, A., et al.. (2006). Low genetic diversity of the intrinsic OXA-51-like class D carbapenemases amongAcinetobacter baumanniiclinical isolates in Greece. Epidemiology and Infection. 135(5). 877–881. 6 indexed citations
14.
Manolis, Evangelos, et al.. (2006). In Vivo Effect of Carbon Dioxide Laser-Skin Resurfacing and Mechanical Abrasion on the Skin's Microbial Flora in an Animal Model. Dermatologic Surgery. 32(3). 359–364. 5 indexed citations
15.
Pournaras, Spyros, Antonios Markogiannakis, A. Ikonomidis, et al.. (2006). Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. Journal of Antimicrobial Chemotherapy. 57(3). 557–561. 133 indexed citations
16.
Spanakis, Nicholas, et al.. (2006). Prevalence of infection by HTLV-I/II among pregnant women and high-risk groups in the Peloponnese peninsula, Greece. International Journal of STD & AIDS. 17(8). 543–546. 9 indexed citations
17.
Pournaras, Spyros, Alexandros Ikonomidis, Antonios Markogiannakis, et al.. (2006). Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems. Journal of Medical Microbiology. 56(1). 66–70. 39 indexed citations
18.
Sofianou, D., et al.. (2005). VIM-2 metallo-β-lactamase in Achromobacter xylosoxidans in Europe. European Journal of Clinical Microbiology & Infectious Diseases. 24(12). 854–855. 18 indexed citations
19.
Pournaras, Spyros, Athanasios Tsakris, Alexandros Ikonomidis, et al.. (2005). Detection of a novel variantblaCTX-M-3extended spectrum β-lactamase gene in a community-acquired Escherichia coli isolate. Scandinavian Journal of Infectious Diseases. 38(3). 213–216. 1 indexed citations
20.
Gazouli, Maria, Εva Tzelepi, Antonios Markogiannakis, N.J. Legakis, & L. S. Tzouvelekis. (1998). Two novel plasmid-mediated cefotaxime-hydrolyzing β-lactamases (CTX-M-5 and CTX-M-6) fromSalmonella typhimurium. FEMS Microbiology Letters. 165(2). 289–293. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesabel I. Rivera Breakdown of academic impact, for papers by Theodoros Karampatakis Breakdown of academic impact, for papers by María Isabel Morosini Breakdown of academic impact, for papers by Laura J. Rojas Breakdown of academic impact, for papers by Agila Kumari Pragasam Breakdown of academic impact, for papers by Doroti de Oliveira Garcia Breakdown of academic impact, for papers by Gianluigi Lombardi Breakdown of academic impact, for papers by Maud Nilsson Breakdown of academic impact, for papers by Fatima M’Zali Breakdown of academic impact, for papers by M. Carmen Conejo
Rankless by CCL
2026